Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want (original) (raw)

• van Panhuis, W. G. et al. Contagious diseases in the United States from 1888 to the present. N. Engl. J. Med. 369, 2152–2158 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Glenny, A. T., Pope, C. G., Waddington, H. & Wallace, U. Immunological notes. XVI1.−XXIV. J. Pathol. Bacteriol. 29, 31–40 (1926).
  Article CAS Google Scholar
• Lindblad, E. B. Aluminium compounds for use in vaccines. Immunol. Cell Biol. 82, 497–505 (2004).
  Article CAS PubMed Google Scholar
• HogenEsch, H. Mechanism of immunopotentiation and safety of aluminum adjuvants. Front. Immunol. 4, 406 (2013).
  Google Scholar
• Reed, S. G., Orr, M. T. & Fox, C. B. Key roles of adjuvants in modern vaccines. Nat. Med. 19, 1597–1608 (2013).
  Article CAS PubMed Google Scholar
• Bonam, S. R., Partidos, C. D., Halmuthur, S. K. M. & Muller, S. An overview of novel adjuvants designed for improving vaccine efficacy. Trends Pharmacol. Sci. 38, 771–793 (2017).
  Article CAS PubMed Google Scholar
• Hem, S. L. & HogenEsch, H. Aluminum-containing adjuvants: properties, formulation, and use. In Vaccine Adjuvants and Delivery Systems (ed. Singh, M.) 81–114 (John Wiley & Sons, Inc., Hoboken, NJ, 2007).
• Hem, S. L. & Johnston, C. T. Production and characterization of aluminum-containing adjuvants. In Vaccine Development and Manufacturing (Eds. Wen, E. P. et al.) 319–346 (John Wiley & Sons, Inc., Hoboken, NJ, 2015).
  Google Scholar
• He, P., Zou, Y. & Hu, Z. Advances in aluminum hydroxide-based adjuvant research and its mechanism. Hum. Vaccin Immunother. 11, 477–488 (2015).
  Article PubMed PubMed Central Google Scholar
• Lindblad, E. B. & Schonberg, N. E. Aluminum adjuvants: preparation, application, dosage, and formulation with antigen. Methods Mol. Biol. 626, 41–58 (2010).
  Article CAS PubMed Google Scholar
• Dey, A. K., Malyala, P. & Singh, M. Physicochemical and functional characterization of vaccine antigens and adjuvants. Expert Rev. Vaccin. 13, 671–685 (2014).
  Article CAS Google Scholar
• Gupta, R. K. Aluminum compounds as vaccine adjuvants. Adv. Drug Deliv. Rev. 32, 155–172 (1998).
  Article CAS PubMed Google Scholar
• Dandashli, E. A. et al. Effect of thermal treatment during the preparation of aluminum hydroxide adjuvant on the protein adsorption capacity during aging. Pharm. Dev. Technol. 7, 401–406 (2002).
  Article CAS PubMed Google Scholar
• Yau, K. P., Schulze, D. G., Johnston, C. T. & Hem, S. L. Aluminum hydroxide adjuvant produced under constant reactant concentration. J. Pharm. Sci. 95, 1822–1833 (2006).
  Article CAS PubMed Google Scholar
• Callahan, P. M., Shorter, A. L. & Hem, S. L. The importance of surface charge in the optimization of antigen-adjuvant interactions. Pharm. Res. 8, 851–858 (1991).
  Article CAS PubMed Google Scholar
• Hsu, P. H. Aluminum oxides and oxyhydroxides. In Minerals in Soil Environments (eds. Dixon, J. B. & Weed, S. B.) 331–378 (Soil Society of America, Madison, WI, 1989).
• Burrell, L. S. et al. Aluminium phosphate adjuvants prepared by precipitation at constant pH. Part I: composition and structure. Vaccine 19, 275–281 (2000).
  Article CAS PubMed Google Scholar
• Hem, S. L., Klepak, P. B. & Lindblad, E. B. Aluminum phosphate adjuvant. In Handbook of Pharmaceutical Excipients (eds. Rowe, R. C. et al.) 40–41 (Pharmaceutical Press, London, 2006).
• Chang, M. F., White, J. L., Nail, S. L. & Hem, S. L. Role of the electrostatic attractive force in the adsorption of proteins by aluminum hydroxide adjuvant. PDA J. Pharm. Sci. Technol. 51, 25–29 (1997).
  CAS PubMed Google Scholar
• Klein, J., Ushio, M., Burrell, L. S., Wenslow, B. & Hem, S. L. Analysis of aluminum hydroxyphosphate vaccine adjuvants by (27)Al MAS NMR. J. Pharm. Sci. 89, 311–321 (2000).
  Article CAS PubMed Google Scholar
• Al-Shakhshir, R. H., Lee, A. L., White, J. L. & Hem, S. L. Interactions in model vaccines composed of mixtures of aluminum-containing adjuvants. J. Colloid Interface Sci. 169, 197–203 (1995).
  Article CAS Google Scholar
• Caulfield, M. J. et al. Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice. Hum. Vaccin 3, 139–145 (2007).
  Article PubMed Google Scholar
• Hem, S. L., Johnston, C. T. & HogenEsch, H. Imject Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvant. Vaccine 25, 4985–4986 (2007).
  Article CAS PubMed Google Scholar
• Cain, D. W., Sanders, S. E., Cunningham, M. M. & Kelsoe, G. Disparate adjuvant properties among three formulations of “alum”. Vaccine 31, 653–660 (2013).
  Article CAS PubMed Google Scholar
• Burrell, L. S. et al. Aluminium phosphate adjuvants prepared by precipitation at constant pH. Part II: physicochemical properties. Vaccine 19, 282–287 (2000).
  Article CAS PubMed Google Scholar
• Wang, S. L., Johnston, C. T., Bish, D. L., White, J. L. & Hem, S. L. Water-vapor adsorption and surface area measurement of poorly crystalline boehmite. J. Colloid Interface Sci. 260, 26–35 (2003).
  Article CAS PubMed Google Scholar
• Morefield, G. L. et al. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23, 1588–1595 (2005).
  Article CAS PubMed Google Scholar
• Harris, J. R. et al. Alhydrogel(R) adjuvant, ultrasonic dispersion and protein binding: a TEM and analytical study. Micron 43, 192–200 (2012).
  Article CAS PubMed Google Scholar
• Kolade, O. O., Jin, W., Tengroth, C., Green, K. D. & Bracewell, D. G. Shear effects on aluminum phosphate adjuvant particle properties in vaccine drug products. J. Pharm. Sci. 104, 378–387 (2015).
  Article CAS PubMed Google Scholar
• Shardlow, E., Mold, M. & Exley, C. From stock bottle to vaccine: elucidating the particle size distributions of aluminum adjuvants using Dynamic Light Scattering. Front. Chem. 4, 48 (2016).
  PubMed Google Scholar
• Art, J. F., Vander Straeten, A. & Dupont-Gillain, C. C. NaCl strongly modifies the physicochemical properties of aluminum hydroxide vaccine adjuvants. Int. J. Pharm. 517, 226–233 (2017).
  Article CAS PubMed Google Scholar
• Morefield, G. L., HogenEsch, H., Robinson, J. P. & Hem, S. L. Distribution of adsorbed antigen in mono-valent and combination vaccines. Vaccine 22, 1973–1984 (2004).
  Article CAS PubMed Google Scholar
• Burrell, L. S., White, J. L. & Hem, S. L. Stability of aluminium-containing adjuvants during aging at room temperature. Vaccine 18, 2188–2192 (2000).
  Article CAS PubMed Google Scholar
• Rabe, M., Verdes, D. & Seeger, S. Understanding protein adsorption phenomena at solid surfaces. Adv. Colloid Interface Sci. 162, 87–106 (2011).
  Article CAS PubMed Google Scholar
• Norde, W. Adsorption of proteins from solution at the solid-liquid interface. Adv. Colloid Interface Sci. 25, 267–340 (1986).
  Article CAS PubMed Google Scholar
• Mahn, A., Lienqueo, M. E. & Asenjo, J. A. Effect of surface hydrophobicity distribution on retention of ribonucleases in hydrophobic interaction chromatography. J. Chromatogr. A 1043, 47–55 (2004).
  Article CAS PubMed Google Scholar
• Van Ramshorst, J. D. The adsorption of diphtheria toxoid on aluminium phosphate. Recl. Trav. Chim. Des. Pays-Bas 68, 169–180 (1949).
  Article Google Scholar
• Seeber, S. J., White, J. L. & Hem, S. L. Predicting the adsorption of proteins by aluminium-containing adjuvants. Vaccine 9, 201–203 (1991).
  Article CAS PubMed Google Scholar
• Hallgren, E., Kalman, F., Farnan, D., Horvath, C. & Stahlberg, J. Protein retention in ion-exchange chromatography: effect of net charge and charge distribution. J. Chromatogr. A 877, 13–24 (2000).
  Article CAS PubMed Google Scholar
• Dagouassat, N. et al. A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine. Vaccine 19, 4143–4152 (2001).
  Article CAS PubMed Google Scholar
• Hansen, B. et al. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response. Vaccine 27, 888–892 (2009).
  Article CAS PubMed Google Scholar
• Egan, P. M., Belfast, M. T., Gimenez, J. A., Sitrin, R. D. & Mancinelli, R. J. Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine. Vaccine 27, 3175–3180 (2009).
  Article CAS PubMed Google Scholar
• Morefield, G. L. et al. Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid. Vaccine 23, 1502–1506 (2005).
  Article CAS PubMed Google Scholar
• Lu, F., Boutselis, I., Borch, R. F. & HogenEsch, H. Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker. Vaccine 31, 4362–4367 (2013).
  Article CAS PubMed Google Scholar
• Zhao, Q. & Sitrin, R. Surface phosphophilicity of aluminum-containing adjuvants probed by their efficiency for catalyzing the P−O bond cleavage with chromogenic and fluorogenic substrates. Anal. Biochem. 295, 76–81 (2001).
  Article CAS PubMed Google Scholar
• Jully, V., Moniotte, N., Mathot, F., Lemoine, D. & Preat, V. Development of a high-throughput screening platform to study the adsorption of antigens onto aluminum-containing adjuvants. J. Pharm. Sci. 104, 557–565 (2015).
  Article CAS PubMed Google Scholar
• Jully, V., Mathot, F., Moniotte, N., Preat, V. & Lemoine, D. Mechanisms of antigen adsorption onto an aluminum-hydroxide adjuvant evaluated by high-throughput screening. J. Pharm. Sci. 105, 1829–1836 (2016).
  Article CAS PubMed Google Scholar
• Ahl, P. L. et al. Quantitative analysis of vaccine antigen adsorption to aluminum adjuvant using an automated high throughput method. PDA J. Pharm. Sci. Technol . 72, 149–162 (2018).
  Article PubMed Google Scholar
• Jendrek, S., Little, S. F., Hem, S., Mitra, G. & Giardina, S. Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants. Vaccine 21, 3011–3018 (2003).
  Article CAS PubMed Google Scholar
• Latour, R. A. The Langmuir isotherm: a commonly applied but misleading approach for the analysis of protein adsorption behavior. J. Biomed. Mater. Res. A 103, 949–958 (2015).
  Article PubMed CAS Google Scholar
• Heimlich, J. M., Regnier, F. E., White, J. L. & Hem, S. L. The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins. Vaccine 17, 2873–2881 (1999).
  Article CAS PubMed Google Scholar
• Jiang, D., Morefield, G. L., HogenEsch, H. & Hem, S. L. Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid. Vaccine 24, 1665–1669 (2006).
  Article CAS PubMed Google Scholar
• Hansen, B., Sokolovska, A., HogenEsch, H. & Hem, S. L. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response. Vaccine 25, 6618–6624 (2007).
  Article CAS PubMed Google Scholar
• Zhu, D. et al. Use of o-phthalaldehyde assay to determine protein contents of Alhydrogel-based vaccines. Vaccine 27, 6054–6059 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Amari, J. V., Levesque, P., Lian, Z., Lowden, T. & deAlwis, U. Concentration determination of a recombinant vaccine antigen adsorbed onto an alum adjuvant by chemiluminescent nitrogen detection. Pharm. Res. 22, 33–37 (2005).
  Article CAS PubMed Google Scholar
• Zhu, D. et al. Development of a direct alhydrogel formulation immunoassay (DAFIA). J. Immunol. Methods 344, 73–78 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ugozzoli, M. et al. Flow cytometry: an alternative method for direct quantification of antigens adsorbed to aluminum hydroxide adjuvant. Anal. Biochem. 418, 224–230 (2011).
  Article CAS PubMed Google Scholar
• Li, M. et al. Quantitative and epitope-specific antigenicity analysis of the human papillomavirus 6 capsid protein in aqueous solution or when adsorbed on particulate adjuvants. Vaccine 34, 4422–4428 (2016).
  Article CAS PubMed Google Scholar
• Westdijk, J. et al. Antigenic fingerprinting of diphtheria toxoid adsorbed to aluminium phosphate. Biologicals 47, 69–75 (2017).
  Article CAS PubMed Google Scholar
• Agnolon, V. et al. Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines. Vaccine 34, 1040–1046 (2016).
  Article CAS PubMed Google Scholar
• Knight, P. A. The relative efficacy of a variety of aluminium adjuvants on tetanus toxoid. Prog. Immunobiol. Stand. 3, 252–257 (1967).
  CAS PubMed Google Scholar
• Seeber, S. J., White, J. L. & Hem, S. L. Solubilization of aluminum-containing adjuvants by constituents of interstitial fluid. J. Parenter. Sci. Technol. 45, 156–159 (1991).
  CAS PubMed Google Scholar
• Lai, X. et al. Determination of adsorbed protein concentration in aluminum hydroxide suspensions by near-infrared transmittance spectroscopy. Appl. Spectrosc. 62, 784–790 (2008).
  Article CAS PubMed Google Scholar
• Clausi, A. L., Merkley, S. A., Carpenter, J. F. & Randolph, T. W. Inhibition of aggregation of aluminum hydroxide adjuvant during freezing and drying. J. Pharm. Sci. 97, 2049–2061 (2008).
  Article CAS PubMed Google Scholar
• al-Shakhshir, R. H., Regnier, F. E., White, J. L. & Hem, S. L. Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants. Vaccine 13, 41–44 (1995).
  Article CAS PubMed Google Scholar
• Rinella, J. V., Workman, R. F., Hermodson, M. A., White, J. L. & Hem, S. L. Elutability of proteins from aluminum-containing vaccine adjuvants by treatment with surfactants. J. Colloid Interface Sci. 197, 48–56 (1998).
  Article CAS PubMed Google Scholar
• Peek, L. J., Martin, T. T., Elk Nation, C., Pegram, S. A. & Middaugh, C. R. Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants. J. Pharm. Sci. 96, 547–557 (2007).
  Article CAS PubMed Google Scholar
• Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W. & Katayama, D. S. Stability of protein pharmaceuticals: an update. Pharm. Res. 27, 544–575 (2010).
  Article PubMed CAS Google Scholar
• Wittayanukulluk, A., Jiang, D., Regnier, F. E. & Hem, S. L. Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen. Vaccine 22, 1172–1176 (2004).
  Article CAS PubMed Google Scholar
• Estey, T. et al. Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry. J. Pharm. Sci. 98, 2994–3012 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Sturgess, A. W. et al. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide. Vaccine 17, 1169–1178 (1999).
  Article CAS PubMed Google Scholar
• Pujar, N. S. et al. Base hydrolysis of phosphodiester bonds in pneumococcal polysaccharides. Biopolymers 75, 71–84 (2004).
  Article CAS PubMed Google Scholar
• Maddux, N. R., Joshi, S. B., Volkin, D. B., Ralston, J. P. & Middaugh, C. R. Multidimensional methods for the formulation of biopharmaceuticals and vaccines. J. Pharm. Sci. 100, 4171–4197 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Dong, A., Jones, L. S., Kerwin, B. A., Krishnan, S. & Carpenter, J. F. Secondary structures of proteins adsorbed onto aluminum hydroxide: infrared spectroscopic analysis of proteins from low solution concentrations. Anal. Biochem. 351, 282–289 (2006).
  Article CAS PubMed Google Scholar
• Agopian, A. et al. Secondary structure analysis of HIV-1-gp41 in solution and adsorbed to aluminum hydroxide by Fourier transform infrared spectroscopy. Biochim. Biophys. Acta 1774, 351–358 (2007).
  Article CAS PubMed Google Scholar
• Iyer, V. et al. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae. J. Pharm. Sci. 101, 3078–3090 (2012).
  Article CAS PubMed Google Scholar
• Jones, L. S. et al. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J. Biol. Chem. 280, 13406–13414 (2005).
  Article CAS PubMed Google Scholar
• Ausar, S. F. et al. Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminum-adjuvanted vaccines. J. Pharm. Sci. 100, 431–440 (2011).
  Article CAS PubMed Google Scholar
• Ljutic, B. et al. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants. Vaccine 30, 2981–2988 (2012).
  Article CAS PubMed Google Scholar
• Regnier, M. et al. Structural perturbation of diphtheria toxoid upon adsorption to aluminium hydroxide adjuvant. Vaccine 30, 6783–6788 (2012).
  Article CAS PubMed Google Scholar
• Wagner, L. et al. Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant. Clin. Vaccin. Immunol. 19, 1465–1473 (2012).
  Article CAS Google Scholar
• Hansen, B. et al. Effect of the strength of adsorption of HIV 1 SF162dV2gp140 to aluminum-containing adjuvants on the immune response. J. Pharm. Sci. 100, 3245–3250 (2011).
  Article CAS PubMed Google Scholar
• Iyer, S., HogenEsch, H. & Hem, S. L. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production. Vaccine 21, 1219–1223 (2003).
  Article CAS PubMed Google Scholar
• Weissburg, R. P. et al. Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. Pharm. Res. 12, 1439–1446 (1995).
  Article CAS PubMed Google Scholar
• Vecchi, S., Bufali, S., Skibinski, D. A., O’Hagan, D. T. & Singh, M. Aluminum adjuvant dose guidelines in vaccine formulation for preclinical evaluations. J. Pharm. Sci. 101, 17–20 (2012).
  Article CAS PubMed Google Scholar
• Baylor, N. W., Egan, W. & Richman, P. Aluminum salts in vaccines—US perspective. Vaccine 20(Suppl 3), S18–S23 (2002).
  Article CAS PubMed Google Scholar
• Jensen, O. M. & Koch, C. On the effect of Al(OH)3 as an immunological adjuvant. APMIS 96, 257–264 (1988).
  Article CAS Google Scholar
• Davis, H. L. Novel vaccines and adjuvant systems: the utility of animal models for predicting immunogenicity in humans. Hum. Vaccin. 4, 246–250 (2008).
  Article CAS PubMed Google Scholar
• Oleszycka, E. & Lavelle, E. C. Immunomodulatory properties of the vaccine adjuvant alum. Curr. Opin. Immunol. 28, 1–5 (2014).
  Article CAS PubMed Google Scholar
• Mannhalter, J. W., Neychev, H. O., Zlabinger, G. J., Ahmad, R. & Eibl, M. M. Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. Clin. Exp. Immunol. 61, 143–151 (1985).
  CAS PubMed PubMed Central Google Scholar
• Ghimire, T. R., Benson, R. A., Garside, P. & Brewer, J. M. Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro. Immunol. Lett. 147, 55–62 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Rimaniol, A. C. et al. Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine 22, 3127–3135 (2004).
  Article CAS PubMed Google Scholar
• Sokolovska, A., Hem, S. L. & HogenEsch, H. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants. Vaccine 25, 4575–4585 (2007).
  Article CAS PubMed Google Scholar
• Calabro, S. et al. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 29, 1812–1823 (2011).
  Article CAS PubMed Google Scholar
• Lu, F. & HogenEsch, H. Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant. Vaccine 31, 3979–3986 (2013).
  Article CAS PubMed Google Scholar
• de Veer, M., Kemp, J., Chatelier, J., Elhay, M. J. & Meeusen, E. N. The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant. Vaccine 28, 6597–6602 (2010).
  Article PubMed CAS Google Scholar
• Hutchison, S. et al. Antigen depot is not required for alum adjuvanticity. FASEB J. 26, 1272–1279 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Holt, L. B. Developments in Diphtheria Prophylaxis (W. Heinemann, Ltd., London, 1950).
• Marichal, T. et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat. Med. 17, 996–1002 (2011).
  Article CAS PubMed Google Scholar
• McKee, A. S. et al. Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells. Proc. Natl. Acad. Sci. USA 110, E1122–E1131 (2013).
  Article CAS PubMed Google Scholar
• Kool, M. et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205, 869–882 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Riteau, N. et al. ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation. Cell Death Dis. 3, e403 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y., Rahman, D. & Lehner, T. A comparative study of stress-mediated immunological functions with the adjuvanticity of alum. J. Biol. Chem. 287, 17152–17160 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sharp, F. A. et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl. Acad. Sci. USA 106, 870–875 (2009).
  Article CAS PubMed Google Scholar
• Oleszycka, E. et al. IL-1alpha and inflammasome-independent IL-1beta promote neutrophil infiltration following alum vaccination. FEBS J. 283, 9–24 (2016).
  Article CAS PubMed Google Scholar
• Rose, W. A. 2nd, Okragly, A. J., Patel, C. N. & Benschop, R. J. IL-33 released by alum is responsible for early cytokine production and has adjuvant properties. Sci. Rep. 5, 13146 (2015).
  Article CAS PubMed Google Scholar
• Li, H., Willingham, S. B., Ting, J. P. & Re, F. Cutting edge: inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3. J. Immunol. 181, 17–21 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Goto, N. & Akama, K. Histopathological studies of reactions in mice injected with aluminum-adsorbed tetanus toxoid. Microbiol. Immunol. 26, 1121–1132 (1982).
  Article CAS PubMed Google Scholar
• Stephen, J. et al. Neutrophil swarming and extracellular trap formation play a significant role in Alum adjuvant activity. NPJ Vaccin. 2, 1 (2017).
  Article CAS Google Scholar
• Yang, C. W., Strong, B. S., Miller, M. J. & Unanue, E. R. Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J. Immunol. 185, 2927–2934 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Liang, F. et al. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake. Sci. Transl. Med. 9, eaal2094 (2017).
  Article PubMed Google Scholar
• Lu, F. et al. Alpha-D-glucan nanoparticulate adjuvant induces a transient inflammatory response at the injection site and targets antigen to migratory dendritic cells. Npj Vaccin. 2, 4 (2017).
  Article Google Scholar
• Ulanova, M., Tarkowski, A., Hahn-Zoric, M. & Hanson, L. A. The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism. Infect. Immun. 69, 1151–1159 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Seubert, A., Monaci, E., Pizza, M., O’Hagan, D. T. & Wack, A. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J. Immunol. 180, 5402–5412 (2008).
  Article CAS PubMed Google Scholar
• Li, H., Nookala, S. & Re, F. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J. Immunol. 178, 5271–5276 (2007).
  Article CAS PubMed Google Scholar
• Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S. & Flavell, R. A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122–1126 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847–856 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kool, M. et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181, 3755–3759 (2008).
  Article CAS PubMed Google Scholar
• Franchi, L. & Nunez, G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38, 2085–2089 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Schnare, M. et al. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2, 947–950 (2001).
  Article CAS PubMed Google Scholar
• Gavin, A. L. et al. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314, 1936–1938 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Flach, T. L. et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat. Med. 17, 479–487 (2011).
  Article CAS PubMed Google Scholar
• Khameneh, H. J. et al. The Syk-NFAT-IL-2 pathway in dendritic cells is required for optimal sterile immunity elicited by alum adjuvants. J. Immunol. 198, 196–204 (2017).
  Article CAS PubMed Google Scholar
• Mori, A. et al. The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses. Eur. J. Immunol. 42, 2709–2719 (2012).
  Article CAS PubMed Google Scholar
• Ramanathan, V. D., Badenoch-Jones, P. & Turk, J. L. Complement activation by aluminium and zirconium compounds. Immunology 37, 881–888 (1979).
  CAS PubMed PubMed Central Google Scholar
• Guven, E., Duus, K., Laursen, I., Hojrup, P. & Houen, G. Aluminum hydroxide adjuvant differentially activates the three complement pathways with major involvement of the alternative pathway. PLoS ONE 8, e74445 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Suresh, R., Chandrasekaran, P., Sutterwala, F. S. & Mosser, D. M. Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation. J. Cell Sci. 129, 1928–1939 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Carroll, M. C. & Isenman, D. E. Regulation of humoral immunity by complement. Immunity 37, 199–207 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Aebig, J. A. et al. Formulation of vaccines containing CpG oligonucleotides and alum. J. Immunol. Methods 323, 139–146 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, T. Y. et al. Rational design of small molecules as vaccine adjuvants. Sci. Transl. Med. 6, 263ra160 (2014).
  Article PubMed CAS Google Scholar
• Didierlaurent, A. M. et al. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J. Immunol. 183, 6186–6197 (2009).
  Article CAS PubMed Google Scholar
• Shi, Y., HogenEsch, H., Regnier, F. E. & Hem, S. L. Detoxification of endotoxin by aluminum hydroxide adjuvant. Vaccine 19, 1747–1752 (2001).
  Article CAS PubMed Google Scholar
• Fox, C. B. Characterization of TLR4 agonist effects on alhydrogel(R) sedimentation: a novel application of laser scattering optical profiling. J. Pharm. Sci. 101, 4357–4364 (2012).
  Article CAS PubMed Google Scholar
• Mullen, G. E. et al. Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen. Vaccine 25, 5343–5347 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Fox, C. B. et al. Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: a formulation approach. J. Control Release 244, 98–107 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Cortez, A. et al. Incorporation of phosphonate into benzonaphthyridine toll-like receptor 7 agonists for adsorption to aluminum hydroxide. J. Med. Chem. 59, 5868–5878 (2016).
  Article CAS PubMed Google Scholar
• Malyala, P. et al. The preparation and physicochemical characterization of aluminum hydroxide/TLR7a, a novel vaccine adjuvant comprising a small molecule adsorbed to aluminum hydroxide. J. Pharm. Sci. 107, 1577–1585 (2018).
  Article CAS PubMed Google Scholar
• Misiak, A. et al. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model. Vaccine 35, 5256–5263 (2017).
  Article CAS PubMed Google Scholar
• Sun, B. et al. Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles. ACS Nano 7, 10834–10849 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Li, X., Aldayel, A. M. & Cui, Z. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. J. Control Release 173, 148–157 (2014).
  Article CAS PubMed Google Scholar
• Li, X. et al. Aluminum (oxy)hydroxide nanosticks synthesized in bicontinuous reverse microemulsion have potent vaccine adjuvant activity. ACS Appl. Mater. Interfaces 9, 22893–22901 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, H. et al. Turning the old adjuvant from gel to nanoparticles to amplify CD8(+) T cell responses. Adv. Sci. (Weinh.) 5, 1700426 (2018).
  Article CAS Google Scholar
• Hassett, K. J. et al. Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants. J. Pharm. Sci. 104, 627–639 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Francica, J. R. et al. Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. Blood Adv. 1, 2329–2342 (2017).
  Article PubMed PubMed Central Google Scholar
• Burny, W. et al. Different adjuvants induce common innate pathways that are associated with enhanced adaptive responses against a model antigen in humans. Front. Immunol. 8, 943 (2017).
  Article PubMed PubMed Central Google Scholar